AETERNUM HEALTH INC (AETN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AETN SEC filings page.
AETERNUM HEALTH INC (AETN) reported $204K in revenue for fiscal year 2025, up 212.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue expanded sharply, but negative equity and zero reported liquidity show a business still dependent on obligations rather than operating earnings.
Gross margin swung from-19.5% in FY2024 to59.0% in FY2025, yet the operating margin remained-132.2% ; improved direct economics were overwhelmed by costs below gross profit. The cash-and-earnings mismatch is equally notable: FY2025 showed a net loss of$337K but operating cash flow of only-$3K , so the reported loss did not translate into an equivalent cash outflow during that period.
The balance sheet signals structural financial pressure: FY2025 liabilities of
Revenue rose from
Financial Health Signals
AETERNUM HEALTH INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
AETERNUM HEALTH INC scores -116.74, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($12.6M) relative to total liabilities ($2.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
AETERNUM HEALTH INC passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
AETERNUM HEALTH INC reported a net loss of $337K while operations used $3K of cash. With neither figure positive, the ratio between the two carries no quality signal.
AETERNUM HEALTH INC reported an operating loss of $269K against $68K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
AETERNUM HEALTH INC reported $1.7M in net income in Q2 2026. This represents an increase of 1727.3% from the same quarter a year earlier. Against the prior quarter it is up 1333.4%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
AETERNUM HEALTH INC held $0 in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
AETN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $2K-98.6% | $24K+88.5% | $8K-46.0% | $7K-78.7% | $165K+4190.2% | $12K+338.7% | $15K+320.1% |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $29K+66.4% |
| Gross Profit | N/A | -$12K-109.6% | $9K+141.6% | -$9K+42.1% | -$6K-117.4% | $125K+1523.5% | -$22K-155.0% | -$15K+6.2% |
| SG&A Expenses | $8K-49.4% | $37K+45.1% | $27K-15.2% | $38K+212.9% | $15K-56.7% | $26K+18.9% | $32K-10.3% | $12K-64.9% |
| Operating Income | -$271K-205.4% | -$120K-625.9% | -$82K | -$121K-9.9% | -$89K+4.2% | $23K+121.6% | N/A | -$110K+0.4% |
| Interest Expense | N/A | $20K+19.4% | $17K0.0% | $17K-1.1% | $17K-27.5% | $17K+38.6% | $17K+327.9% | $17K-43.8% |
| Net Income | $1.7M+1727.3% | -$140K-2470.7% | -$99K | -$138K-78.6% | -$106K+9.0% | $6K+105.0% | N/A | -$77K+45.3% |
| EPS (Basic) | $0.03 | $0.00-100.0% | -$0.010.0% | $0.00 | $0.00 | $0.01 | -$0.01 | $0.00 |
| EPS (Diluted) | $0.03 | $0.00-100.0% | -$0.010.0% | $0.00 | $0.00 | $0.01 | -$0.01 | $0.00 |
| Diluted Shares (Avg) | 55M | 50M+3.5% | N/A | 49M+1.5% | 49M+1.5% | 49M+14.4% | N/A | 48M+1.4% |
Not reported in any period shown, so not listed: R&D Expenses, EBITDA, Income Tax.
AETN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M+1230.6% | $75K-58.7% | $55K-16.6% | $74K+1.4% | $145K+59.6% | $182K-13.3% | $65K-78.8% | $73K-83.2% |
| Current Assets | $1.9M+1239.8% | $59K-67.3% | $54K-16.9% | $73K+1.4% | $144K+60.3% | $181K-13.4% | $64K-79.1% | $72K-83.4% |
| Cash & Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0-100.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | N/A | $39K+105.1% | $37K-16.9% | $18K-47.0% | $19K+4.3% | $19K+158.3% | $45K+551.0% | $35K+142.2% |
| Accounts Receivable | $0-100.0% | $866-99.5% | $984 | $843-94.3% | $102K+607.1% | $162K | $0-100.0% | $15K+492.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.3M+19.1% | $2.1M+16.3% | $2.1M+17.9% | $2.0M+22.6% | $1.9M+23.0% | $1.8M+20.9% | $1.7M+13.5% | $1.6M+6.2% |
| Current Liabilities | N/A | $1.2M+32.6% | $1.1M+38.0% | $1.1M+52.7% | $987K+62.7% | $918K+74.8% | $822K+63.9% | $690K+71.1% |
| Non-Current Liabilities | N/A | $920K0.0% | $920K0.0% | $920K0.0% | $920K-2.5% | $920K-7.6% | $920K-11.0% | $920K-17.3% |
| Total Equity | -$341K+80.6% | -$2.1M-24.5% | -$2.0M-19.3% | -$1.9M-23.6% | -$1.8M-20.7% | -$1.7M-23.3% | -$1.7M-36.7% | -$1.5M-35.1% |
| Retained Earnings | -$1.7M+42.9% | -$3.4M-16.4% | -$3.3M-11.5% | -$3.2M-13.5% | -$3.0M-11.6% | -$2.9M-14.0% | -$2.9M-18.1% | -$2.8M-19.4% |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
AETN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.5M-8436.6% | -$56K-206.7% | -$39K-3574.3% | $36K+546.0% | $18K+124.7% | -$18K+81.7% | -$1K+98.8% | -$8K+81.5% |
| Stock-Based Compensation | N/A | $2K-89.5% | N/A | N/A | N/A | $14K | N/A | N/A |
| Financing Cash Flow | $2.2M | $60K | N/A | N/A | N/A | N/A | -$1+100.0% | -$24K-83.4% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
AETN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | -530.0% | 38.1% | -103.3% | -79.2%-176.7pp | 76.1% | -172.5% | -96.4% |
| Operating Margin | N/A | -5289.8% | -350.0% | -1449.3% | -1245.6% | 13.8% | N/A | -712.9% |
| Net Margin | N/A | -6179.4% | -421.9% | -1652.0% | -1486.3% | 3.6% | N/A | -499.9% |
| Return on Assets | 89.3%+162.3pp | -186.2%-189.5pp | -182.0% | -186.2%-80.5pp | -73.0%+55.0pp | 3.3%+59.4pp | N/A | -105.7%-73.2pp |
| Current Ratio | N/A | 0.05-0.1x | 0.050.0x | 0.070.0x | 0.150.0x | 0.20-0.2x | 0.08-0.5x | 0.10-1.0x |
| Asset Turnover | N/A | 0.03-0.9x | 0.43+0.2x | 0.11-0.1x | 0.05-0.3x | 0.91+0.9x | 0.19+0.2x | 0.21+0.2x |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$2.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.05), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where AETERNUM HEALTH INC Ranks
Frequently Asked Questions
What is AETERNUM HEALTH INC's annual revenue?
AETERNUM HEALTH INC (AETN) reported $204K in total revenue for fiscal year 2025. This represents a 212.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AETERNUM HEALTH INC's revenue growing?
AETERNUM HEALTH INC (AETN) revenue grew by 212.7% year-over-year, from $65K to $204K in fiscal year 2025.
Is AETERNUM HEALTH INC profitable?
No, AETERNUM HEALTH INC (AETN) reported a net income of -$337K in fiscal year 2025.
What is AETERNUM HEALTH INC's gross margin?
AETERNUM HEALTH INC (AETN) had a gross margin of 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is AETERNUM HEALTH INC's operating cash flow?
AETERNUM HEALTH INC (AETN) recorded an outflow of $3K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are AETERNUM HEALTH INC's total assets?
AETERNUM HEALTH INC (AETN) had $55K in total assets as of fiscal year 2025, including both current and long-term assets.
What is AETERNUM HEALTH INC's current ratio?
AETERNUM HEALTH INC (AETN) had a current ratio of 0.05 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is AETERNUM HEALTH INC's return on assets (ROA)?
AETERNUM HEALTH INC (AETN) had a return on assets of -617.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is AETERNUM HEALTH INC's P/E ratio?
AETERNUM HEALTH INC (AETN) trades at 9.4x earnings, its market capitalization divided by net income of $1.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $12.6M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AETERNUM HEALTH INC's price-to-sales ratio?
AETERNUM HEALTH INC (AETN) trades at 62.1x sales, its market capitalization divided by revenue of $204K revenue, FY2025. The market capitalization is $12.6M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does AETERNUM HEALTH INC's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, AETERNUM HEALTH INC (AETN) held $0 in cash, cash equivalents and investments, and reported an operating cash outflow of $3K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is AETERNUM HEALTH INC's debt-to-equity ratio negative or not reported?
AETERNUM HEALTH INC (AETN) has negative shareholder equity of -$2.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is AETERNUM HEALTH INC's Altman Z-Score?
AETERNUM HEALTH INC (AETN) has an Altman Z-Score of -116.74, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is AETERNUM HEALTH INC's Piotroski F-Score?
AETERNUM HEALTH INC (AETN) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AETERNUM HEALTH INC's earnings high quality?
AETERNUM HEALTH INC (AETN) reported a net loss of $337K while operations used $3K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can AETERNUM HEALTH INC cover its interest payments?
AETERNUM HEALTH INC (AETN) reported an operating loss of $269K against $68K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.